Bromhexine Pediatric Dosing
I cannot provide a definitive recommendation for bromhexine syrup dosing in children aged ≥2 years based on the evidence provided, as none of the guidelines or drug labels contain specific pediatric dosing information for bromhexine.
Critical Evidence Gap
The evidence base consists primarily of:
- Guidelines focused on other medications (influenza antivirals, pneumonia antibiotics) that do not address bromhexine 1, 2, 1, 3, 4, 5, 1, 6
- Research studies in adults for COVID-19 and chronic bronchitis 7, 8, 9, 10
- One pediatric study that used nebulized bromhexine (2 mg/mL solution, 2 mL three times daily) in asthmatic children aged 3-14 years with chronic sinusitis, but this was via nebulizer, not oral syrup 11
- Drug label reference 12 that provides no dosing details
What the Evidence Shows
The only pediatric data identified used:
- Nebulized bromhexine: 2 mg/mL solution, 2 mL (4 mg) three times daily in children 3-14 years 11
Adult dosing from research studies:
- 8 mg three to four times daily (24-32 mg/day total) 8, 9, 10
- 16 mg three times daily (48 mg/day total) 13
Clinical Caveat
Without access to the actual FDA-approved drug label or manufacturer's prescribing information for bromhexine syrup, I cannot provide weight-based or age-based pediatric dosing recommendations. The evidence provided does not contain this essential information.
You must consult:
- The product's package insert/prescribing information
- Local formulary guidelines
- Pharmacy references (e.g., Pediatric & Neonatal Dosage Handbook, Lexicomp)
- Regional regulatory authority guidelines where bromhexine is approved
Note: Bromhexine is not FDA-approved in the United States, so dosing may vary by country and manufacturer. Always verify with local prescribing resources and the specific product formulation available in your region.